Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
DIABETES UNIT
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01281072
First received: January 20, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted

January 20, 2011
January 20, 2011
Not Provided
Not Provided
c peptide reserve
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)
Not Provided

Open label study to evaluate long term treatment effect of diapep277.

Not Provided
Interventional
Phase 3
Intervention Model: Single Group Assignment
Giving a Vaccination in Three Months
Other: vaccine
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

1. patient that completed 901 and 910 study.

Exclusion Criteria:

1. cpeptide<0.2

Both
20 Years to 50 Years
Not Provided
Not Provided
 
NCT01281072
911-DIAPEP277
No
PROP ITAMAR RAZ, HADASSAH MEDICAL CENTER
Hadassah Medical Organization
DIABETES UNIT
Not Provided
Hadassah Medical Organization
January 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP